Gennova Bio joins CEPI to develop vax against Nipah virus – The Economic Times

1. Gennova Bio joins CEPI to develop vax against Nipah virus  The Economic Times
2. Gennova, CEPI ink pact to develop AI-enhanced Nipah vaccine with $13.4 million funding  Moneycontrol
3. Pune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine  The Indian Express
4. AI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses  CEPI
5. Gennova partners with CEPI to develop saRNA vaccine for Nipah virus  financialexpress.com

 Gennova Bio joins CEPI to develop vax against Nipah virus  The Economic TimesGennova, CEPI ink pact to develop AI-enhanced Nipah vaccine with $13.4 million funding  MoneycontrolPune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine  The Indian ExpressAI-enhanced self-amplifying mRNA vaccine set to combat one of the deadliest known viruses  CEPIGennova partners with CEPI to develop saRNA vaccine for Nipah virus  financialexpress.com  Top stories – Google News